Clinical Trial: Efficacy and Safety of MRG003 in Combination with Putolimab as Neoadjuvant Therapy for Locally Advanced Oropharyngeal Squamous Cell Carcinoma: A Phase II, Single-Arm, Multicenter Clinical Study (China)

China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of MRG003 in Combination with Putolimab as Neoadjuvant Therapy for Locally Advanced Oropharyngeal Squamous Cell Carcinoma: A Phase II, Single-Arm, Multicenter Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131390

Registration Time: 2026/09/01

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327581

Published by HT Digital Content Services with permission from Health Daily Digest....